查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1695221

2025年全球尿失禁市場報告

Urinary Incontinence Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年尿失禁市場規模將強勁成長。預計到 2029 年將成長至 173.9 億美元，複合年成長率為 6.8%。預測期內的成長歸因於併發症的增加、生活方式因素、人口健康策略以及醫療保健支出的增加。預測期內的關鍵趨勢包括醫學進步、創新技術、非侵入性治療、數位健康和​​行動醫療、創新產品設計和以患者為中心的護理。

泌尿系統疾病盛行率的不斷上升將在不久的將來為尿失禁市場擴張提供重大動力。泌尿系統疾病包括影響泌尿器官系統和男性生殖器官的各種疾病，包括腎臟、膀胱、輸尿管、尿道、前列腺和睪丸等主要組成部分。泌尿器官系統疾病盛行率的快速成長，尤其是尿失禁等疾病，推動了對旨在解決這些醫療問題的產品和治療方案的需求。人們對泌尿系統疾病的認知和診斷不斷提高，以及醫療解決方案和醫療保健基礎設施的發展，進一步推動了該市場的成長。例如，根據美國癌症協會截至2023年1月的最新資料，預計2023年美國泌尿系統膀胱癌病例數將達到82,290例，較2020年記錄的81,400例增加1.1%。這證實了尿失禁市場擴張的成長勢頭，這主要是由於泌尿系統疾病的盛行率不斷上升。

預計微創手術的需求不斷成長將在短期內推動尿失禁市場的成長。微創手術包括手術程序和干涉，涉及使用專門的器械和先進的技術來減少手術期間所需的切口的大小和數量。對此類微創手術的需求日益成長，在尿失禁治療中發揮關鍵作用，提供了一種有效且對患者友好的治療方法。越來越多的患者和醫療保健提供者選擇這些方法來控制症狀，同時盡量減少對患者日常生活和整體健康的影響。例如，截至 2023 年 1 月，美國機器人產品製造商 Intuitive Surgical Inc. 報告稱，2022 年使用 Vinci Surgical Systems 進行了約 187.5 萬例手術。與 2021 年使用 Vinci Surgical Systems 進行的約 1,594,000 例手術相比，這一數字成長了 18%。因此，對微創手術日益成長的需求預計將成為尿失禁市場成長的主要驅動力。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 世界尿失禁PESTEL分析（政治、社會、科技、環境、法律因素、促進因素、抑制因素）
  • 最終用途產業分析
  • 全球尿失禁市場：成長率分析
  • 全球尿失禁市場表現：規模與成長，2019-2024
  • 全球尿失禁市場預測：2024-2029年及2034年規模與成長
  • 全球尿失禁總目標市場（TAM）

第6章市場區隔

  • 全球尿失禁市場：按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 急性尿失禁
  • 應力性尿失禁
  • 充溢性尿失禁
  • 功能性尿失禁
  • 全球尿失禁市場（依治療類型、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 藥品
  • 裝置
  • 其他治療方法
  • 全球尿失禁市場：依給藥途徑、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 口服
  • 腸外
  • 其他給藥途徑
  • 全球尿失禁市場（依診斷、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 身體檢查
  • 墊片測試
  • 尿動力學檢查
  • 膀胱鏡檢查
  • 壓力測試
  • 超音波
  • 尿液樣本
  • 全球尿失禁市場：依最終用戶、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 專科診所
  • 居家護理
  • 其他最終用戶
  • 全球尿失禁市場，依急性尿失禁類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 膀胱過動症
  • 尿急
  • 全球尿失禁市場，依應力性尿失禁類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 體力活動期間不自主漏尿
  • 咳嗽和打噴嚏
  • 全球尿失禁市場，依溢流性尿失禁類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 慢性閉尿症滯留
  • 頻繁或持續滴尿
  • 全球尿失禁市場功能性尿失禁細分市場，依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 認知障礙
  • 身體限制

第7章 區域和國家分析

  • 全球尿失禁市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球尿失禁市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 尿失禁市場：競爭格局
  • 尿失禁市場：公司簡介
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
    • Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Becton Dickinson and Company（CR Bard Inc.）
  • Teva Pharmaceutical Industries Ltd.
  • Berry Global Inc.
  • Boston Scientific Corporation
  • Mylan NV
  • Sun Pharmaceutical Industries Ltd.
  • Domtar Corporation
  • Cook Medical Inc.
  • Aurobindo Pharma Ltd
  • Coloplast AIS
  • Teleflex Incorporated
  • Apotex Inc.
  • Zydus Lifesciences Limited
  • ConvaTec Group PLC
  • Cook Group Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年尿失禁市場：提供新機會的國家
  • 2029年尿失禁市場：細分領域帶來新機會
  • 2029年尿失禁市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r29200

Urinary incontinence is a medical condition characterized by the involuntary loss of urine, which can range from occasional leaks to a complete inability to control urination. This condition can be caused by various factors, including weakened pelvic floor muscles, hormonal changes, obesity, neurological conditions, urinary tract infections, certain medications, and pregnancy.

The primary categories of urinary incontinence include urge incontinence, stress incontinence, overflow incontinence, and functional incontinence. Urge incontinence, also known as overactive bladder, is typified by a sudden and intense urge to urinate that is difficult to control. This type is typically managed through medications that help calm and control bladder muscles, along with behavioral techniques such as bladder training and lifestyle adjustments. Various treatments, including medications and medical devices, are administered through oral, parenteral, and other routes to address urinary incontinence. Diagnostic tools and services, such as physical examinations, pad tests, urodynamic testing, cystoscopy, stress tests, ultrasound scans, and urine samples, are provided by a range of end users, including hospitals, specialty clinics, homecare services, and others.

The urinary incontinence market research report is one of a series of new reports from The Business Research Company that provides urinary incontinence market statistics, including urinary incontinence industry global market size, regional shares, competitors with a urinary incontinence market share, detailed urinary incontinence market segments, market trends and opportunities and any further data you may need to thrive in the urinary incontinence industry. This urinary incontinence market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The urinary incontinence market size has grown strongly in recent years. It will grow from $12.52 billion in 2024 to $13.37 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, awareness of urinary incontinence, rising prevalence of urinary incontinence, increasing access to healthcare, rising disposable incomes.

The urinary incontinence market size is expected to see strong growth in the next few years. It will grow to $17.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing prevalence of comorbidities, lifestyle factors, population health strategies, growing healthcare expenditures. Major trends in the forecast period include medical advancements, innovative technologies, non-invasive treatments, digital health and mhealth, innovative product designs, patient-centered care.

The increasing prevalence of urological disorders is set to provide significant impetus to the expansion of the urinary incontinence market in the near future. Urological disorders encompass a wide array of medical conditions affecting the urinary system and male reproductive organs, which includes critical components like the kidneys, bladder, ureters, urethra, prostate, and testes. This upsurge in the prevalence of urological disorders, with a particular emphasis on conditions like urinary incontinence, is driving the demand for products and treatment options designed to address these healthcare concerns. The rising awareness and diagnosis of urological disorders, in conjunction with ongoing developments in medical solutions and healthcare infrastructure, are further bolstering the growth of this market. For instance, recent data from January 2023, as reported by the American Cancer Society Inc., reveals that the estimated cases of urinary bladder cancer in the United States have reached 82,290 in 2023, signifying a 1.1% increase from the 81,400 cases recorded in 2020. This underscores the momentum behind the expansion of the urinary incontinence market, primarily driven by the growing incidence of urological disorders.

The increasing demand for minimally invasive procedures is anticipated to be a driving force for the growth of the urinary incontinence market in the foreseeable future. Minimally invasive procedures encompass surgical techniques and interventions that involve the utilization of specialized instruments and advanced technology to reduce the size and quantity of incisions required during surgery. This heightened demand for minimally invasive procedures plays a crucial role in managing urinary incontinence, offering an effective and patient-friendly approach to its treatment. Patients and healthcare providers are increasingly opting for these methods to address the condition while minimizing the impact on a patient's daily life and overall well-being. For instance, as of January 2023, reports from Intuitive Surgical Inc., a US-based manufacturer of robotic products, indicate that approximately 1,875,000 surgical procedures were performed using Vinci Surgical Systems in 2022. This reflects an impressive 18% increase compared to the approximately 1,594,000 procedures conducted with Vinci Surgical Systems in 2021. Therefore, the mounting demand for minimally invasive procedures is set to be a significant driver behind the growth of the urinary incontinence market.

Prominent companies within the urinary incontinence market are proactively adopting cutting-edge technologies and groundbreaking approaches to elevate patient care and enhance treatment outcomes. For instance, in July 2023, UroMems SAS, a biotechnology firm based in France, successfully carried out the implantation of the UroActive smart artificial urinary sphincter (AUS) in a female patient for the treatment of stress urinary incontinence (SUI) in women. This groundbreaking UroActive device is powered by a myoelectrical mechanical system (MEMS) meticulously engineered to address the unmet need for a definitive SUI treatment in women. The procedure was conducted with robotic assistance at La Pitie-Salpetriere University Hospital in Paris and garnered regulatory approval from the French equivalent of the FDA. UroActive's adaptability, intelligent functionality, and minimally invasive approach collectively aim to enhance the quality of life for patients.

In September 2023, Amber Therapeutics, a medtech company based in the UK, acquired Bioinduction Limited for an undisclosed amount. Through this acquisition, Amber gained access to the Picostim DyNeuMo neuromodulation therapy platform. Amber is now utilizing this advanced implantable system to provide closed-loop therapy specifically developed for mixed urinary incontinence, known as Amber-UI. Bioinduction Limited, also a UK-based medical device company, specializes in neuromodulation devices targeting urinary incontinence.

Major companies operating in the urinary incontinence market are Cardinal Health Inc., Johnson and Johnson, Medtronic PLC, Eli Lilly and Company, Asahi Kasei Corporation, Becton Dickinson and Company (C.R. Bard Inc.), Teva Pharmaceutical Industries Ltd., Berry Global Inc., Boston Scientific Corporation, Mylan N.V., Sun Pharmaceutical Industries Ltd., Domtar Corporation, Cook Medical Inc., Aurobindo Pharma Ltd., Coloplast AIS, Teleflex Incorporated, Apotex Inc., Zydus Lifesciences Limited, ConvaTec Group PLC, Cook Group Inc., Torrent Pharmaceuticals Ltd., Alennbic Pharmaceuticals Limited, Laborie Medical Technologies Corp., NeoTract Inc., Ethicon Inc., Promedon GmbH, Caldera Medical Inc.

North America was the largest region in the urinary incontinence market in 2024. The regions covered in urinary incontinence report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the urinary incontinence market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The urinary incontinence market includes revenues earned by entities by providing medical diagnosis and evaluation, medication and surgical interventions, pelvic floor muscle training and physical therapy, behavioral therapies and bladder training and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The urinary incontinence market also includes sales of electrical stimulation devices, foley catheters, antimicrobial foley catheters and urethral bulking agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Urinary Incontinence Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on urinary incontinence market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for urinary incontinence ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The urinary incontinence market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Urge Incontinence; Stress Incontinence; Overflow Incontinence; Functional Incontinence
  • 2) By Treatment Type: Medication; Devices; Other Treatments
  • 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administrations
  • 4) By Diagnosis: Physical Exam; Pad Test; Urodynamic Testing; Cystoscopy; Stress Test; Ultrasound; Urine Samples
  • 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
  • Subsegments:
  • 1) By Urge Incontinence: Overactive Bladder; Urinary Urgency
  • 2) By Stress Incontinence: Involuntary Leakage During Physical Activity; Coughing Or Sneezing
  • 3) By Overflow Incontinence: Chronic Urinary Retention; Frequent Or Constant Dribbling
  • 4) By Functional Incontinence: Cognitive Impairment; Physical Limitations
  • Companies Mentioned: Cardinal Health Inc.; Johnson and Johnson; Medtronic plc; Eli Lilly and Company; Asahi Kasei Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Urinary Incontinence Market Characteristics

3. Urinary Incontinence Market Trends And Strategies

4. Urinary Incontinence Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Urinary Incontinence Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Urinary Incontinence PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Urinary Incontinence Market Growth Rate Analysis
  • 5.4. Global Urinary Incontinence Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Urinary Incontinence Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Urinary Incontinence Total Addressable Market (TAM)

6. Urinary Incontinence Market Segmentation

  • 6.1. Global Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urge Incontinence
  • Stress Incontinence
  • Overflow Incontinence
  • Functional Incontinence
  • 6.2. Global Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medication
  • Devices
  • Other Treatments
  • 6.3. Global Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Parenteral
  • Other Routes Of Administrations
  • 6.4. Global Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Physical Exam
  • Pad Test
  • Urodynamic Testing
  • Cystoscopy
  • Stress Test
  • Ultrasound
  • Urine Samples
  • 6.5. Global Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Other End-Users
  • 6.6. Global Urinary Incontinence Market, Sub-Segmentation Of Urge Incontinence, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Overactive Bladder
  • Urinary Urgency
  • 6.7. Global Urinary Incontinence Market, Sub-Segmentation Of Stress Incontinence, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Involuntary Leakage During Physical Activity
  • Coughing Or Sneezing
  • 6.8. Global Urinary Incontinence Market, Sub-Segmentation Of Overflow Incontinence, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chronic Urinary Retention
  • Frequent Or Constant Dribbling
  • 6.9. Global Urinary Incontinence Market, Sub-Segmentation Of Functional Incontinence, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cognitive Impairment
  • Physical Limitations

7. Urinary Incontinence Market Regional And Country Analysis

  • 7.1. Global Urinary Incontinence Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Urinary Incontinence Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Urinary Incontinence Market

  • 8.1. Asia-Pacific Urinary Incontinence Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Urinary Incontinence Market

  • 9.1. China Urinary Incontinence Market Overview
  • 9.2. China Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Urinary Incontinence Market

  • 10.1. India Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Urinary Incontinence Market

  • 11.1. Japan Urinary Incontinence Market Overview
  • 11.2. Japan Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Urinary Incontinence Market

  • 12.1. Australia Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Urinary Incontinence Market

  • 13.1. Indonesia Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Urinary Incontinence Market

  • 14.1. South Korea Urinary Incontinence Market Overview
  • 14.2. South Korea Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Urinary Incontinence Market

  • 15.1. Western Europe Urinary Incontinence Market Overview
  • 15.2. Western Europe Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Urinary Incontinence Market

  • 16.1. UK Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Urinary Incontinence Market

  • 17.1. Germany Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Urinary Incontinence Market

  • 18.1. France Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Urinary Incontinence Market

  • 19.1. Italy Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Urinary Incontinence Market

  • 20.1. Spain Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Urinary Incontinence Market

  • 21.1. Eastern Europe Urinary Incontinence Market Overview
  • 21.2. Eastern Europe Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Urinary Incontinence Market

  • 22.1. Russia Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Urinary Incontinence Market

  • 23.1. North America Urinary Incontinence Market Overview
  • 23.2. North America Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Urinary Incontinence Market

  • 24.1. USA Urinary Incontinence Market Overview
  • 24.2. USA Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Urinary Incontinence Market

  • 25.1. Canada Urinary Incontinence Market Overview
  • 25.2. Canada Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Urinary Incontinence Market

  • 26.1. South America Urinary Incontinence Market Overview
  • 26.2. South America Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Urinary Incontinence Market

  • 27.1. Brazil Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Urinary Incontinence Market

  • 28.1. Middle East Urinary Incontinence Market Overview
  • 28.2. Middle East Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Urinary Incontinence Market

  • 29.1. Africa Urinary Incontinence Market Overview
  • 29.2. Africa Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Urinary Incontinence Market Competitive Landscape And Company Profiles

  • 30.1. Urinary Incontinence Market Competitive Landscape
  • 30.2. Urinary Incontinence Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Urinary Incontinence Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company (C.R. Bard Inc.)
  • 31.2. Teva Pharmaceutical Industries Ltd.
  • 31.3. Berry Global Inc.
  • 31.4. Boston Scientific Corporation
  • 31.5. Mylan N.V.
  • 31.6. Sun Pharmaceutical Industries Ltd.
  • 31.7. Domtar Corporation
  • 31.8. Cook Medical Inc.
  • 31.9. Aurobindo Pharma Ltd
  • 31.10. Coloplast AIS
  • 31.11. Teleflex Incorporated
  • 31.12. Apotex Inc.
  • 31.13. Zydus Lifesciences Limited
  • 31.14. ConvaTec Group PLC
  • 31.15. Cook Group Inc.

32. Global Urinary Incontinence Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Urinary Incontinence Market

34. Recent Developments In The Urinary Incontinence Market

35. Urinary Incontinence Market High Potential Countries, Segments and Strategies

  • 35.1 Urinary Incontinence Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Urinary Incontinence Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Urinary Incontinence Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer